Mogamulizumab-kpkc Intravenous and Palladone
Determining the interaction of Mogamulizumab-kpkc Intravenous and Palladone and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: mogamulizumab
Brand name: Poteligeo
Synonyms: Mogamulizumab
Generic Name: hydromorphone
Brand name: Dilaudid, Exalgo, Hydrostat IR, Dilaudid-HP
Synonyms: Palladone (Oral)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Mogamulizumab-kpkc Intravenous-Palmitate-A
- Mogamulizumab-kpkc Intravenous-Palonosetron
- Mogamulizumab-kpkc Intravenous-Palonosetron Hydrochloride
- Mogamulizumab-kpkc Intravenous-Palonosetron Hydrochloride Injection
- Mogamulizumab-kpkc Intravenous-Palonosetron injection
- Mogamulizumab-kpkc Intravenous-Palonosetron Intravenous
- Palladone-Molindone
- Palladone-Mometasone (Oral Inhalation)
- Palladone-Mometasone and Formoterol
- Palladone-Mometasone and formoterol Inhalation
- Palladone-Mometasone Cream
- Palladone-Mometasone Furoate